Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Arzneimittelkommission der deutschen Ärzteschaft (2009) 23. Arterielle Hypertonie: Arzneiverordnungen, 22. Aufl. Medizinische Medien Informations GmbH, Neu-Isenburg, S 597–628
Barron AJ, Zaman N, Cole GD, Wensel R, Okonko DO, Francis DP (2013) Sytematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information. Int J Cardiol 168:3572–3579
Bowman AJ, Chen CP, Ford GA (1994) Nitric oxide mediated venodilator effects of nebivolol. Brit J Clin Pharmacol 38:199–204
Chatterjee S, Biondi-Zoccai G, Abbate A, D’Ascenzo F, Castagno D, Van Tassell B, Mukherjee D, Lichstein E (2013) Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ 346:f596
Chobanian AV et al (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). JAMA 289:2560–2572 (Erratum in: JAMA 2003, 920:197)
CIBIS II Study (1999) The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial. Lancet 353:9–13
Gulea C, Zakeri R, Alderman V, Morgan A, Ross J, Quint JK (2021) Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison. Resp Res 22:64. https://doi.org/10.1186/s12931-021-01661-8
Grundt C, Meier K, Grundt A, Lemmer B (2007) Evidence for an estradiol-agonistic action of nebivolol in spontaneously hypertensive rats. J Hypertens 25:1001–1007
Kintscher U, Böhm M, Goss F, Kolloch R, Kreutz R, Schmieder R, Schunkert H (2014) Kommentar zur 2013-ESH/ESC-Leitlinie zum Management der arteriellen Hypertonie. Kardiologie 8:223–230
Léauté-Labrèze C, Hoeger P, Mazereew-Hautier J et al (2015) A randomized, controlled trial of propranolol in infantile hemangioma. N Eng J Med 19:735–746
MERIT-HF Study (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet 353:2001–2007
Moen MD, Wagstaff AJ (2006) Nebivolol – a review of its use in the management of hypertension and chronic heart failure. Drugs 66:1389–1409
Packer M, Coats AJS, Fowler MB, Katus HA et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658
POISE Study Group (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial) a randomized controlled trial. Lancet 371:1839–1847
Sackner-Bernstein J (2005) Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy. Clin Cardiol 28(11 Suppl 1):19–27
Thomopoulos C, Parati G, Zanchetti A (2015) Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihyperten-sive drugs – overview and meta-analyses. J Hypertens 33:195–211
Tzemos N, Lim PO, MacDonald TM (2001) Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 104:511–514
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39:3021–3104
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Lemmer, B. (2021). Betarezeptorenblocker. In: Ludwig, WD., Mühlbauer, B., Seifert, R. (eds) Arzneiverordnungs-Report 2021. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63825-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-662-63825-5_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-63824-8
Online ISBN: 978-3-662-63825-5
eBook Packages: Medicine (German Language)